Research in my laboratory is focused on tumor immunology in primary and metastatic brain cancer. We identified different disease-associated roles of brain metastasis-associated myeloid and lymphoid populations using multiomics and image-based approaches. Based on this mechanistic insight, we seek to develop novel immune-targeted therapies for preclinical testing in ex vivo and in vivo models. We put a particular emphasis on strategies that overcome inherent or adaptive resistance mechanisms by modulating immune cell activation states and targeting metabolic pathways in brain metastasis. Such approaches comprise strategies for local immune modulation within the brain metastatic microenvironment as well as systemic approaches e.g. by targeted modification of the microbiome for immune stimulation. To validate the translational significance of our experimental data, we utilize patient samples for in depth immunophenotyping and correlation with patient prognosis.
Experimental Neuroonco-Immunology
Biosketch
Prof. Dr. Lisa Sevenich is a biologist focusing on tumor immunology in brain cancer. She earned her PhD at the University of Freiburg in 2010. This was followed by a postdoctoral fellowship at Memorial Sloan Kettering Cancer Center, New York, NY, USA under the guidance of Prof. Johanna Joyce. In 2015, she was awarded with the Max-Eder Junior fellowship (German Cancer Aid) and started her research group at the Georg-Speyer-Haus. In 2023, she accepted a call for W2 professorship at the Medical Faculty of the University of Tübingen with affiliations at the M3 Research Center, the Department of Neurology and Interdisciplinary Neurology, Hertie Institute for Clinical Brain Research (HIH) and the Cluster of Excellence “Image-guided and functionally instructed tumor therapies (iFIT).
Co-Affiliations
-
Cluster of Excellence “Image-guided and functionally instructed tumor therapies (iFIT)
-
Department of Neurology and Interdisciplinary Neurooncology, Hertie Institute for Clinical Brain Research (HIH)
Moreover, we seek to identify tumor cell vulnerabilities for targeted therapies using advanced ex vivo brain cancer models for systematic screening of drug libraries. Additionally, we seek to gain mechanistic insight into tumor cell characteristics that allow tumor cells to adopt to the unique tissue environment in the central nervous system. A focus is put on the acquisition of neuronal-like characteristics in brain metastatic cells as a core program of metastatic niche cooption with regard to metabolic and immunological processes. Our mission is to provide scientific rationale for novel therapeutic strategies against brain metastasis.
tumor
immunology
immune
metabolism
microbiome
Selected publications
- Möckl A and Sevenich L: Take my breath away: TAMing anti-cancer immunity in hypoxic niches. (2023) Immunity Aug8;56(8):1704-1706 doi:10.1016/j.immuni.2023.07.010
- Klemm F, Möckl A, Salamero-Boix A, Alekseeva T, Schäffer A, Schulz M, Niesel K, Maas RR, Groth M, Elie BT, Bowman RL, Hegi ME, Daniel RT, Zeiner PS, Zinke J, Harter PN, Plate KH, Joyce JA and Sevenich L: Compensatory CSF2-driven macrophage activation promotes adaptive resistance to CSF1R inhibition in breast-to-brain metastasis. (2021) Nat Cancer 2, 1086-1101 doi: 10.1038/s43018-021-00254-0.
- Niesel K, Schulz M, Alekseeva T, Anthes J, Salamero-Boix A, Möckl A., Oberwahrenbrock T, Lolies M, Stein S, Rödel F, Sevenich L: The immune suppressive microenvironment affects efficacy of radio-immunotherapy in brain metastasis. (2021) EMBO Mol Med e13421 doi: 10.15252/emmm.202013412.
- Schulz M, Michels B, Niesel K, Stein S, Farin H, Rödel F, Sevenich L: Cellular and molecular changes in the myeloid cell compartment during disease progression and therapeutic response in lung-to-brain metastasis. (2020) iScience Jun26;23(6):101178 doi: 10.1016/j.isci.2020.101178.
- Chae WH, Niesel K, Schulz M, Klemm F, Joyce JA, Prümmer M, Brill B, Bergs J, Rödel F, Pilatus U, Sevenich L: Evaluating magnetic resonance spectroscopy as a tool for monitoring therapeutic response of whole brain radiotherapy in a mouse model for breast-to-brain metastasis. (2019) Front Oncol. 27(9):1324 doi: 10.3389/fonc.2019.01324.
- Sevenich L, Bowman RL, Mason SD, Quail DF, Rapaport F, Elie BT, Brogi E, Brastianos PK, Hahn WC, Holsinger LJ, Massague J, Leslie CS, Joyce JA: Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain metastasis-promoting role for cathepsin S. (2014). Nat Cell Biol. 16(9):876-888 doi: 10.1038/ncb3011.
- Pyonteck SM, Akkari L, Schuhmacher AJ, Bowman RL, Sevenich L, Quail DF, Olson OC, Quick M, Huse J, Teijeiro V, Setty M, Leslie C, Oei Y, Pedraza A, Zhang J, Brennan CW, Sutton JC, Holland EC, Daniel D, Joyce JA: CSF-1R inhibition alters macrophage polarization and blocks glioma progression. (2013) Nat Med. 19(10):1264-72